Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02429284 · ClinicalTrials.gov registry record
U.S. CTEPH Registry
A clinical trial, sponsored by University of California, San Diego.
- Completed
- Registry status
- 754
- Enrollment target
NCT02429284 is a clinical trial that has completed, run by University of California, San Diego. The registered enrollment target is 754 participants.
The verdict
NCT02429284 has completed, sponsored by University of California, San Diego.
- COMPLETED
- Registry status
- 754 participants
- Enrollment target
Study Summary
The U.S. CTEPH Registry is a multicenter, observational, U.S.-based study of the clinical course and treatment of patients diagnosed with chronic thromboembolic pulmonary hypertension (CTEPH), WHO Group IV Classification for Pulmonary Hypertension. The mission of the Registry will be to promote a greater understanding of the prevalence, pathophysiology, evaluation, and treatment of patients with CTEPH through shared information, education, and collaborative investigation among pulmonary hypertension (PH) centers of excellence throughout the U.S.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 754 participants |
| Start Date | 2015-04 |
| Est. Completion | 2019-11 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02429284
The ClinicalTrials.gov registry entry for NCT02429284 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 754 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of California, San Diego, which has 775 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT02429284 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02429284 about?
NCT02429284 is a clinical study titled "U.S. CTEPH Registry". The U.S. CTEPH Registry is a multicenter, observational, U.S.-based study of the clinical course and treatment of patients diagnosed with chronic thromboembolic pulmonary hypertension (CTEPH), WHO Group IV Classification for Pulmonary Hypertension. The mission of the Registry will be to promote a gr...
What is the current status of trial NCT02429284?
This trial is currently completed. The enrollment target is 754 participants. The study started on 2015-04. Estimated completion is 2019-11.
Who is sponsoring clinical trial NCT02429284?
This trial is sponsored by University of California, San Diego, which has 775 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.